GeneDx Holdings (WGS)

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Aksjekursen GeneDx Holdings Corp. Class A Common Stock (WGS) after-hours i dag er 74,32 $, som gjenspeiler en bevegelse på −6,64 % after-hours siden markedet sist stengte. Selskapets markedsverdi er $ 2,15 mrd., med et daglig handelsvolum på $ 1,25 mill. aksjer. For investorer som følger kursutviklingen, har GeneDx Holdings Corp. Class A Common Stock-aksjen ligget mellom 73,37 $  og 78,37 $ i dag. Den forrige lukkekursen var 79,61 $.

Er du klar til å komme i gang? Følg trinnene nedenfor, eller les vår guide om hvordan kjøpe GeneDx Holdings aksje på Kraken fra $10.